Abstract
Non-melanoma skin cancer (NMSC), comprising basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), is the most common malignancy worldwide. The incidence of NMSC is increasing with 2–3 million new diagnoses per year globally. Australia, with chronic high ultraviolet (UV) exposure, has the highest incidence of NMSC in the world, with the majority of cSCCs (70–90 %) arising on the sun-exposed skin of the head and neck (HN) in older Caucasian males [1–4].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
de Vries E, van de Poll-Franse LV, Louwman WJ, et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481–8.
Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancers. Int J Radiat Oncol Biol Phys. 2001;51:748–55.
Veness MJ, Porceddu S, Palme CE, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31.
Ebrahimi A, Moncrieff MD, Clark JR, et al. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck. 2010;32:1288–94.
Rodgers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7.
Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer. 1998;78:587–93.
Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78:144–8.
Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.
Katz MH. Nonmelanoma skin cancer. Md Med J. 1997;46:239–42.
Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136:1524–30.
Schmults CD, Karia PS, Carter JB, et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149:541–7.
Motley RJ, Kersey P, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2003;56:85–91.
Czarnecki D, Staples M, Mar A, et al. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. 1994;189:52–4.
Wang JT, Palme CE, Morgan GJ, et al. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2011;34:1524–8.
Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2012;82:230–3.
Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115:1883–91.
Givi B, Andersen PE, Diggs BS, et al. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2011;33:999–1004.
Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101–8.
Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870–5.
Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatology (BAD); 2009. p. 34. http://www.guideline.gov/content.aspx?id=15882.
National Comprehensive Cancer Network (NCCN). Practice guidelines in oncology: basal cell and squamous cell skin cancers. Available at www.nccn.org/professionals/5hysician_gls/PDF/nmsc.pdf. Accessed on 24 Sept 2013.
Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2006;28:785–91.
Hinerman RW, Indelicato DJ, Amdur RJ, et al. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope. 2008;118:1989–96.
Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol. 1992;26:976–90.
Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. J Am Acad Dermatol. 1989;21:241–8.
Stein AL, Tahan SR. Histologic correlates of metastasis in primary invasive squamous cell carcinoma of the lip. J Cutan Pathol. 1994;21:16–21.
Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998;124:582–7.
Rodolico V, Barresi E, Di Lorenzo R, et al. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27kip1 protein expression. Oral Oncol. 2004;40:92–8.
Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94:624–7.
Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification—part two. J Cutan Pathol. 2006;33:261–79.
Breuninger H, Schaumburg-Lever G, Holzschuh J, et al. Desmoplastic squamous cell carcinoma of the skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer. 1997;79:915–9.
Ballantyne AJ. Perineural invasion by squamous cell carcinoma. J Dermatol Surg Oncol. 1984;10:502–4.
Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Moh’s micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53:261–6.
Ross AS, Whalen FM, Elenitsas R, et al. Diameter of involved nerves predicts outcome in cutaneous squamous cell carcinoma with perineural invasion: an investigator blinded retrospective cohort study. Dermatol Surg. 2009;35:1859–66.
Brougham ND, Dennett ER, Cameron R, et al. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106:811–5.
Huang CC, Boyce SM. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Semin Cutan Med Surg. 2004;23:163–73.
Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27:241–8.
Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003;112:57–63.
Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Moh’s micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53:253–60.
Duvvuri U, Simental Jr AA, D’Angelo G, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope. 2004;114:2228–34.
Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg. 2005;242:302–11; discussion 311–13.
Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18:2529–37.
Howle J, Veness M. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead Hospital experience. Australas J Dermatol. 2012;53:26–31.
Morton DL. Overview and update of the phase III MSLT-I and MSLT-II in melanoma. Clin Exp Metastasis. 2012;29:699–706.
Vermeeren L, Valdés Olmos RA, Klop WM, et al. SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck. 2011;33:1–6.
Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006;112 Suppl 109:1–15.
Altinyollar H, Berberoglu U, Çelen O, et al. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol. 2002;28:72–4.
Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol. 2011;9:80.
Wong G, Chapman JR. Cancers after renal transplantation. Transplant Rev. 2008;22:141–9.
Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990;49:506–9.
Jensen P, Hansen S, Møller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177–86.
Lindelöf B, Sigurgeirsson B, Gäbel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513–9.
Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol. 2006;142:755–8.
Deeb R, Sharma S, Mahan M, et al. Head and neck cancer in transplant recipients. Laryngoscope. 2012;122:1566–9.
Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996;61:715–21.
Webb MC, Compton F, Andrews PA, et al. Skin tumours post-transplantation: a retrospective analysis of 28 years’ experience at a single centre. Transplant Proc. 1997;29:828–30.
Veness MJ. The important role of radiotherapy in patients with NMSC and other cutaneous entities. J Med Imaging Radiat Oncol. 2008;52:278–86.
Jambusaria-Pahlajani A, Miller CJ, Quon H, et al. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009;35:574–85.
Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer. 2007;109:1053–9.
Mendenhall WM, Ferlito A, Takes RP, et al. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol. 2012;48:918–22.
Jambusaria-Pahlajani A, Hess SD, Katz KA, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol. 2010;146:1225–31.
Panizza B, Solares CA, Redmond M, et al. Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2012;34:1622–7.
Hwang H, Perez D, Orloff L. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope. 2009;119:1958–65.
Bron LP, Traynor SJ, McNeil EB, et al. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113:1070–5.
Uren RF. Lymphatic drainage of skin. Ann Surg Oncol. 2004;11(3 Suppl):179S–85.
Forest VI, Clark JJ, Veness MJ, et al. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer. 2010;116:1298–304.
Kelder W, Ebrahimi A, Forest V, et al. Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread. Ann Surg Oncol. 2012;19:274–9.
O’Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stages, extent of surgery and pathologic findings in metastatic cutaneous squamous cell carcinoma of the parotid gland. Head Neck. 2002;24:417–22.
Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a mulitcenter study of treatment outcomes. Cancer. 2006;106:1078–83.
American Joint Committee on Cancer. AJCC cancer staging handbook. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 301–14.
Brunner M, Veness MJ, Ch’ng S, et al. Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IV. Head Neck. 2013;35:72–5.
O’Hara J, Ferlito A, Takes RP, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland—a review of current recommendations. Head Neck. 2011;33:1789–95.
Ambrosch P, Kron M, Pradier O, et al. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001;124:180–7.
Chepeha DB, Hoff PT, Taylor RJ, et al. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112:434–8.
Patel RS, Clark JR, Gao K, et al. Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck. 2008;30:1231–6.
Shepard PM, Olsen J, Harari PM, et al. Therapeutic selective neck dissection outcomes. Otolaryngol Head Neck Surg. 2010;142:741–6.
Robbins KT, Ferlito A, Shah JP, et al. The evolving role of selective neck dissection for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270:1195–202.
Wang JT, Palme CE, Wang AY, et al. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. J Laryngol Otol. 2013;127 Suppl 1:S2–7.
D’Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck. 2011;19:99–105.
Iyer NG, Clark JR, Murali R, et al. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation. Head Neck. 2009;31:21–7.
Cappiello J, Piazza C, Giudice M, et al. Shoulder disability after different selective neck dissections (levels II–IV versus levels II–V): a comparative study. Laryngoscope. 2005;115:259–63.
Stuiver MM, van Wilgen CP, de Boer EM, et al. Impact of shoulder complaints after neck dissection on shoulder disability and quality of life. Otolaryngol Head Neck Surg. 2008;139:32–9.
Veness MJ, Palme CE, Smith M, et al. Cutaneous head and neck squamous cell carcioma metastatic to cervical lymph nodes (non-parotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope. 2003;113:1827–33.
Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope. 2009;119:1994–9.
Ebrahimi A, Clark J, Lorincz BB, et al. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient. Head Neck. 2012;34:365–70.
Euvrard S, Morelon E, Rostaing L, TUMORAPA Study Group, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39.
Pramana A, Browne L, Graham PH. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy. J Med Imaging Radiat Oncol. 2012;56:100–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Faruque Riffat, Carsten E. Palme, Michael Veness, Rehan Kazi, Raghav C. Dwivedi
About this chapter
Cite this chapter
Jameson, C., Morgan, G., Palme, C.E., Veness, M. (2015). Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. In: Riffat, F., Palme, C., Veness, M. (eds) Non-melanoma Skin Cancer of the Head and Neck. Head and Neck Cancer Clinics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2497-6_8
Download citation
DOI: https://doi.org/10.1007/978-81-322-2497-6_8
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2496-9
Online ISBN: 978-81-322-2497-6
eBook Packages: MedicineMedicine (R0)